N(6)-disubstituted adenoisine compounds and therapeutic compositions
    2.
    发明授权
    N(6)-disubstituted adenoisine compounds and therapeutic compositions 失效
    N(6) - 二取代腺苷化合物和治疗组合物

    公开(公告)号:US3966916A

    公开(公告)日:1976-06-29

    申请号:US525795

    申请日:1974-11-21

    IPC分类号: C07H19/16 A61K31/70

    CPC分类号: C07H19/16

    摘要: New N(6)-disubstituted adenosine compound of the formula ##SPC1##WhereinR.sub.1 is lower alkyl substituted by at least one of hydroxyl, alkoxy or acyloxy; or is cycloalkyl or straight-chained or branched lower alkenyl;R.sub.2 and R.sub.3 are hydrogen, halogen, or nitro or lower alkyl, alkoxy or alkylthio andR.sub.4 is hydrogen or acyl; when R.sub.4 is acyl, R.sub.1 can also be lower alkyl;And the pharmacologicaly compatible salts thereof; exhibits shown anti-lipolytic, anti-hyperlipaemic and anti-hypercholesterolaemic action.

    摘要翻译: 新的N(6) - 二取代的腺苷化合物,式WHERE R1是被羟基,烷氧基或酰氧基中的至少一个取代的低级烷基; 或是环烷基或直链或支链低级链烯基; R2和R3是氢,卤素或硝基或低级烷基,烷氧基或烷硫基,R4是氢或酰基; 当R 4是酰基时,R 1也可以是低级烷基; 及其药理学兼容性; 展示了抗脂肪,抗高血压和抗高血脂药物作用。